Home › Type 2 Diabetes › California
Type 2 Diabetes clinical trials in California
66 studies for Type 2 Diabetes are looking for participants at sites in California.
Cities in California
- San Diego16 studies
- Los Angeles15 studies
- Long Beach11 studies
- Concord10 studies
- Simi Valley8 studies
- Sacramento8 studies
- Mountain View7 studies
- El Cajon7 studies
- Escondido6 studies
- Chula Vista6 studies
- Roseville5 studies
- Pomona5 studies
- Santa Clarita5 studies
- Ontario4 studies
- Torrance4 studies
- Lancaster4 studies
- Westminster4 studies
- San Bernardino4 studies
- Santa Monica4 studies
- San Francisco3 studies
- Santa Barbara3 studies
- Carson3 studies
- West Covina3 studies
- Huntington Beach3 studies
- Tustin3 studies
- South Gate3 studies
Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
- Stanford University, Stanford
Recruiting
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06836479A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Cardiovascular Research Foundation of Southern California, Beverly Hills
- Amicis Research: Beverly Hills, Beverly Hills
- Valiance Clinical Research - Canoga Park, Canoga Park
- and 21 more
RecruitingHealthy volunteers welcome
Ages 55 and older · All sexes · Updated Sep 28, 2026 · NCT06112418A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Escondido
- Research Site, Lincoln
- Research Site, Walnut Creek
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07776509A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Thrive Clinical Research Group, Glendora
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Bakersfield
- Research Site, Gardena
- Research Site, Lincoln
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- San Fernando Valley Health Institute, Canoga Park
- AMCR Institute, Escondido
- NorCal Medical Research, Inc, Greenbrae
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07282600A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- San Fernando Valley Health, Canoga Park
- John Muir Physician Network Clinical Research Center, Concord
- Neighborhood Healthcare - Escondido, Escondido
- and 9 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07754461A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
- Research Site, Glendale
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Sep 16, 2026 · NCT07723833A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Banning
- AURORA-2 Clinical Site, Chula Vista
- AURORA-2 Clinical Site, Covina
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
- Clinical Trial Site, Chula Vista
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 16, 2026 · NCT07465224EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- National Heart Institute, Beverly Hills
- Hope Clinical Research, Canoga Park
- John Muir Physician Network Clinical Research Center, Concord
- and 11 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Core Healthcare Group, Cerritos
- Ark Clinical Research - Long Beach, Long Beach
- Flourish Research - Walnut Creek - PPDS, Walnut Creek
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 15, 2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Orange County Research Center, Lake Forest
- Ark Clinical Research, Long Beach
- Catalina Research Institute, LLC, Montclair
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Wolverine Clinical Trials, Santa Ana
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 14, 2026 · NCT06897475Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
- UC Davis Medical Center, Sacramento
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07176793A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- First Valley Medical Group, Lancaster
- Torrance Clinical Research Institute, Inc., Lomita
- Ark Clinical Research, Long Beach
- and 3 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 11, 2026 · NCT07415954Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- AME Clinical Research, Huntington Beach
- Amicis Research Center, Northridge
- FOMAT - Vista del Mar Medical Group, Oxnard
- and 6 more
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 11, 2026 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Ark Clinical Research, Fountain Valley
- Ark Clinical Research, Long Beach
- Los Angeles Institute for Metabolic Research, Los Angeles
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 11, 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Covina
- Research Site, Encinitas
- Research Site, Garden Grove
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Velocity Clinical Research, Huntington Park, Huntington Park
- Velocity Clinical Research - Gardena, La Mesa
- and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- San Fernando Valley Health Institute, Canoga Park
- Core Healthcare Group, Cerritos
- Velocity Clinical Research Chula Vista, Chula Vista
- and 1 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684144A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Concord
- Research Site, Sacramento
- Research Site, Victorville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- First Valley Medical Group, Lancaster
- Headlands Research CTR Lincoln, Lincoln
- Torrance Clin Res Inst, Inc., Lomita
- and 6 more
RecruitingPhase 3
Ages 45 and older · All sexes · Updated Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Bakersfield
- Research Site, Los Angeles
- Research Site, Ontario
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Lomita
- Research Site, Los Alamitos
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662044A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Lincoln
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT07606066A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
- Research Site, Glendale
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Aug 12, 2026 · NCT07024823Food Insecurity Reduction & Strategy Team
- Stanford Medicine, Palo Alto
Recruiting
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT06329375A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Division of Endocrinology, Diabetes, and Metabolism, Los Angeles
- UCLA Mattel Children's Hospital, Los Angeles
- University of California, San Francisco, San Francisco
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Aug 7, 2026 · NCT06739122Safer Aging With Diabetes Monitoring
- Kaiser Permanente Sacramento, Sacramento
Recruiting
Ages 75 and older · All sexes · Updated Aug 4, 2026 · NCT06296485A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Sacramento
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07664553Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- University of Southern California, Los Angeles
- Sansum Diabetes Research Institute, Santa Barbara
Recruiting
Ages 14 to 75 · All sexes · Updated Aug 3, 2026 · NCT07579702Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- University of Southern California, Los Angeles
- HOAG, Newport Beach
- Sansum Diabetes Research Institute, Santa Barbara
- and 1 more
Recruiting
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07521475A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
- Orange County Research Center, Lake Forest
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07590193Time Restricted Eating in Patients With Microalbuminuria
- Altman Clinical and Translational Research Institute, La Jolla
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Jul 14, 2026 · NCT06884059CGM for Management of Type 2 Diabetes in Pregnancy
- University of California at San Diego, San Diego
Recruiting
Ages 18 to 50 · Women · Updated Jun 29, 2026 · NCT06628453Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age
- Scripps Chula Vista Diabetes Center, Chula Vista
- Scripps Whittier Diabetes Institute, San Diego
Recruiting
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT05416060Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Hope Clinical Research, Canoga Park
- Ark Clinical Research, Long Beach
- Catalina Research Institute, LLC, Montclair
- and 1 more
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 15, 2026 · NCT07502508THC Effects on Glucose in Type 2 Diabetes
- UC San Diego Altman Clinical & Translational Research Institute, La Jolla
RecruitingPhase 1
Ages 21 to 70 · All sexes · Updated Jun 15, 2026 · NCT05322213From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.